Celentyx Ltd

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Celentyx Ltd

Feb 2, 2025, 19:47 | Science

TNBC modifies the systemic immune landscape and alters neutrophil functionality

John Gordon, VP Scientific Affairs at Celentyx Ltd, shared an article by Noor A. M.…

Nov 6, 2024, 12:01 | Insight

John Gordon: Dual “ON/OFF”-switch CARs offer a safer CAR T cell therapy

John Gordon, Vice president of Scientific Affairs at Celentyx Ltd, shared a post on LinkedIn: “Dual ‘ON/OFF’-switch CARs…

All: 2 Posts: 1 - 100

'

Who From Oncology is Featured in TIME100 Health 2025?

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023